Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Association between hematological parameters and high-density lipoprotein cholesterol.

Patrick M Moriarty1, Cheryl A Gibson

  • 1Department of Internal Medicine, University of Kansas School of Medicine, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. pmoriart@kumc.edu

Current Opinion in Cardiology
|June 16, 2005
PubMed
Summary

High-density lipoprotein cholesterol (HDL-C) improves vascular health by enhancing hemorheology, specifically reducing blood viscosity. This involves improving red blood cell aggregation and deformability, benefiting cardiovascular disease prevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoprotein apheresis in the era of new lipid-lowering therapies.

European heart journal·2026
Same author

Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial.

American journal of Alzheimer's disease and other dementias·2026
Same author

Evinacumab with or without lipoprotein apheresis in homozygous familial hypercholesterolaemia.

European journal of preventive cardiology·2026
Same author

Evinacumab in patients aged 5-17 years with homozygous familial hypercholesterolemia.

Atherosclerosis·2026
Same author

Assessing pharmacists' knowledge and practices involving dietary supplement omega-3 fatty acids.

Journal of clinical lipidology·2025
Same author

Pelacarsen: Mechanism of action and Lp(a)-lowering effect.

Journal of clinical lipidology·2025

Area of Science:

  • Cardiovascular Science
  • Hemodynamics
  • Biochemistry

Background:

  • High-density lipoprotein cholesterol (HDL-C) is recognized for its role in reversing atherosclerosis and reducing cardiovascular disease (CVD) risk.
  • Vascular protection by HDL-C is partly mediated through its effects on hemorheology, the study of blood flow.
  • Understanding these mechanisms is crucial for developing novel CVD prevention strategies.

Purpose of the Study:

  • To review the science of hemorheology, focusing on blood viscosity.
  • To examine the association between high-density lipoprotein cholesterol (HDL-C) and hemorheological factors.
  • To explore how HDL-C influences blood flow dynamics and vascular health.

Main Methods:

  • Literature review of randomized controlled trials and scientific studies on HDL-C and hemorheology.

Related Experiment Videos

  • Analysis of rheological mediators, including red blood cell aggregation, deformability, and plasma viscosity.
  • Investigation of nitric oxide release pathways activated by HDL-C.

    • Main Results:

    • Elevated high-density lipoprotein cholesterol (HDL-C) levels positively impact hemorheological mediators, potentially reducing blood viscosity.
    • HDL-C can stimulate endothelial nitric oxide synthase, leading to nitric oxide release and vasodilation.
    • Changes in nitric oxide levels induced by HDL-C may further modulate blood rheology.

    Conclusions:

    • High-density lipoprotein cholesterol (HDL-C) plays a significant role in vascular protection through beneficial effects on blood rheology.
    • Improving hemorheological factors like blood viscosity is a key mechanism by which HDL-C exerts its cardioprotective effects.
    • Further research into HDL-C and hemorheology may offer new therapeutic targets for cardiovascular disease.